Pancreatic perfusion: Noninvasive quantitative assessment with dynamic contrast-enhanced MR imaging without and with secretin stimulation in healthy volunteers - Initial results

Radiology

Volumn 247, Issue 1, 2008, Pages 115-121

  Bali, Maria Antonietta ^a   Metens, Thierry ^a   Denolin, Vincent ^a,c   De Maertelaer, Viviane ^b   Devière, Jacques ^a   Matos, Celso ^a  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c PHILIPS RESEARCH LABORATORIES   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GADODIAMIDE; SECRETIN; CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE;

ADULT; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS PERFUSION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; PANCREAS; PANCREAS FUNCTION TEST; REFERENCE VALUE; VASCULARIZATION;

ADULT; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PANCREAS; PANCREATIC FUNCTION TESTS; REFERENCE VALUES; SECRETIN;

EID: 42449126649     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2471070685     Document Type: Article

References (25)

1. Kubo S, Yamamoto K, Magata Y, et al. Assessment of pancreatic blood flow with positron emission tomography and oxygen-15 water. Ann Nucl Med 1991;5(4):133-138.
2. D'Onofrio M, Zamboni G, Faccioli N, Capelli P, Pozzi Mucelli R. Ultrasonography of the pancreas. 4. Contrast-enhanced imaging. Abdom Imaging 2007;32(2):171-181.
3. Sofuni A, Iijima H, Moriyasu F, et al. Differential diagnosis of pancreatic tumors using ultrasound contrast imaging. J Gastroenterol 2005;40(5):518-525.
4. Miles KA, Hayball MP, Dixon AK. Measurement of human pancreatic perfusion using dynamic computed tomography with perfusion imaging. Br J Radiol 1995;68(809):471-475.
5. Bize PE, Platon A, Becker CD, Poletti PA. Perfusion measurement in acute pancreatitis using dynamic perfusion MDCT. AJR Am J Roentgenol 2006;186(1):114-118.
6. McMenamin DA, Gates LK Jr. A retrospective analysis of the effect of contrast-enhanced CT on the outcome of acute pancreatitis. Am J Gastroenterol 1996;91(7):1384-1387.
7. Carmona-Sanchez R, Uscanga L, Bezaury-Rivas P, Robles-Diaz G, Suazo-Barahona J, Vargas-Vorackova F. Potential harmful effect of iodinated intravenous contrast agent medium on the clinical course of mild acute pancreatitis. Arch Surg 2000;135(11):1280-1284.
8. Hwang TL, Chang KY, Ho YP. Contrast-enhancement dynamic computed tomography does not aggravate the clinical severity of patients with severe acute pancreatitis. Arch Surg 2000;135(3):287-290.
9. Tajima Y, Matsuzaki S, Furui J, Isomoto I, Hayashi K, Kanematsu T. Dynamic magnetic resonance imaging to evaluate remnant pancreatic fibrosis. Br J Surg 2004;91(5):595-600.
10. Coenegrachts K, Van Steenbergen W, De Keyzer F, et al. Dynamic contrast-enhanced MRI of the pancreas: initial results in healthy volunteers and patients with chronic pancreatitis. J Magn Reson Imaging 2004;20(6):990-997.
11. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusible tracer: standarized quantities and symbols. J Magn Reson Imaging 1999;10(3):223-232.
12. Materne R, Smith AM, Peeters F, et al. Assessment of hepatic perfusion parameters with dynamic MRI. Magn Reson Med 2002;47(1):135-142.
13. Pruessmann KP, Weiger M, Scheidegger MB, Boesiger P. SENSE: sensitivity encoding for fast MRI. Magn Reson Med 1999;42(5):952-962.
14. In den Kleef JJ, Cuppen JJ. RLSQ: T1, T2, and rho calculations, combining ratios and least squares. Magn Reson Med 1987;5(6):513-524.
15. Brix G, Kiessling F, Lucht R, et al. Microcirculation and microvasculature in breast tumors: pharmacokinetic analysis of dynamic MR image series. Magn Reson Med 2004;52(2):420-429.
16. Guyton AC, Hall JE. Secretory function of the alimentary tract. In: Textbook of medical physiology. 9th ed. Philadelphia, Pa: Saunders, 1996; 815-876.
17. Holton P, Jones M. Some observations on changes in the blood content of the cat's pancreas during activity. J Physiol 1960;150:479-488.
18. Eichelter P, Schenk WG Jr. Hemodynamics of pancreatic secretion: with observations on pancreatic oxygen consumption. Arch Surg 1966;93(1):200-207.
19. Delaney JP, Grim E. Influence of hormones and drugs on canine pancreatic blood flow. Am J Physiol 1966;211(6):1398-1402.
20. Chung RS, Safaie-Shirazi S. The effect of secretin on pancreatic blood flow in the awake and anesthetized dog. Proc Soc Exp Biol Med 1983;173(4):620-625.
21. Widdison AL, Karanjia ND, Reber HA. Pancreatic vascular regulation in chronic pancreatitis in cats. Gut 1995;36(1):133-136.
22. Dreiling DA, Messer J. The secretin story. Am J Gastroenterol 1978;70(5):455-479.
23. Aune S, Semb LS. The effect of secretin and pancreozymin on pancreatic blood flow in the conscious and anesthetized dog. Acta Physiol Scand 1969;76(4):406-414.
24. Annet L, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers BE. Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiology 2003;229(2):409-414.
25. Peeters F, Annet L, Hermoye L, Van Beers BE. Inflow correction of hepatic perfusion measurements using T1-weighted, fast gradient-echo, contrast-enhanced MRI. Magn Reson Med 2004;51(4):710-717.